| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 2871908 | The Annals of Thoracic Surgery | 2015 | 10 Pages |
Abstract
Pulmonary metastases exhibit patient-specific epigenetic clonality, which may be exploited for precision therapies targeting aberrant CT or TS gene expression. PRC-2 may be a shared target for epigenetic therapy of pulmonary metastases.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Emily S. MD, Julie A. MS, David M. MD, Saïd C. MD, Mary MS, David S. MD, MBA,